Keeping you safe
Our response to COVID-19
Keeping our customers and team members safe, informed and connected is our top priority. As we have been recognized as an essential service, here is what we are doing to protect and support you.
Helping you stay connected and protected
For Mobility customers:
-
Waiving all Easy Roam®, Travel Passes and pay-per-use roaming charges for postpaid and small business customers until April 30
For all customers:
-
Offering FREE educational activities encouraging families to ‘Learn, Do and Share’ with our friends at Microsoft
-
Offering FREE TELUS Wise digital safety online workshops and printable activities for youth
-
Offering flexible payment options for consumer and small business customers who have been financially affected by the crisis
All Connected For Good
At TELUS, building stronger, healthier communities and helping those who need it the most have always been at the core of our values and purpose. In response to the ongoing COVID-19 crisis, we are stepping up even further by utilizing our technology and resources to ensure that we are helping some of the most vulnerable Canadians. Actions include:
-
Supporting communities with medical technology and equipment through a $10M commitment from the TELUS Friendly Future Foundation.
-
Empowering School Boards working with us in Alberta and BC to extend our Internet for Good offer directly to families in need to ensure that school-aged children have the connectivity they need to learn from home
-
Our CEO, Darren Entwistle, is donating his salary for the next three months to our front-line healthcare workers battling COVID-19. This donation will be matched by the Entwistle Family Foundation, which supports Internet for Good, doubling the donation’s positive impact.
-
Enabling healthcare practitioners and social workers to sustain contact with at-risk individuals who are isolated with no means of communication by donating over 2000 prepaid devices and SIM cards valued at $1.2M through our Mobility for Good program.
-
Donating $500K toward the research and development of antivirals.
